05-Nov-2025
Download PDF
Solara Active
Solara Active Pharma Sciences Limited has informed the Exchange regarding the following items approved at the Board Meeting held on November 05 2025: 1. Appointment of Mr. Sarat Kumar Asuri CFO as the Chief Investor Relations Officer.2. Change in remuneration of the Whole Time Director Mr. Mohan Muthunarayanan.3. Change in the remuneration of the eligible Senior Management Personnels.4. Review and confirmation of Risk Management Policy.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
